Valneva SE banner

Valneva SE
PAR:VLA

Watchlist Manager
Valneva SE Logo
Valneva SE
PAR:VLA
Watchlist
Price: 2.564 EUR 0.55% Market Closed
Market Cap: €441.5m

Valneva SE
Intangible Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Valneva SE
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
Valneva SE
PAR:VLA
Intangible Assets
€22.3m
CAGR 3-Years
-8%
CAGR 5-Years
-9%
CAGR 10-Years
-14%
G
Genfit SA
PAR:GNFT
Intangible Assets
€4.2m
CAGR 3-Years
-54%
CAGR 5-Years
39%
CAGR 10-Years
21%
Inventiva SA
PAR:IVA
Intangible Assets
€85k
CAGR 3-Years
-48%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
Cellectis SA
PAR:ALCLS
Intangible Assets
$535k
CAGR 3-Years
-9%
CAGR 5-Years
-20%
CAGR 10-Years
-6%
DBV Technologies SA
PAR:DBV
Intangible Assets
$22k
CAGR 3-Years
30%
CAGR 5-Years
-12%
CAGR 10-Years
-14%
Abivax SA
PAR:ABVX
Intangible Assets
€6.6m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Valneva SE
Glance View

Market Cap
441.5m EUR
Industry
Biotechnology

Valneva SE is a biotech company. The company is headquartered in Saint-Herblain, Pays De La Loire and currently employs 722 full-time employees. The company went IPO on 2007-06-28. The firm's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The firm has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The firm is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

VLA Intrinsic Value
3.103 EUR
Undervaluation 17%
Intrinsic Value
Price €2.564

See Also

What is Valneva SE's Intangible Assets?
Intangible Assets
22.3m EUR

Based on the financial report for Dec 31, 2025, Valneva SE's Intangible Assets amounts to 22.3m EUR.

What is Valneva SE's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
-14%

Over the last year, the Intangible Assets growth was -12%. The average annual Intangible Assets growth rates for Valneva SE have been -8% over the past three years , -9% over the past five years , and -14% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett